Gad Abikhzer1, Patrick Martineau2,3, Jean Grégoire4, Vincent Finnerty4, Francois Harel4, Matthieu Pelletier-Galarneau5,6. 1. Department of Radiology and Nuclear Medicine, Jewish General Hospital, Montreal, QC, Canada. 2. Department of Radiology, University of Manitoba, Winnipeg, MB, Canada. 3. Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, USA. 4. Department of Medical Imaging, Montreal Heart Institute, 5000 Bélanger, Montreal, QC, H1T1C8, Canada. 5. Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, USA. matthieu.pelletier-galarneau@icm-mhi.org. 6. Department of Medical Imaging, Montreal Heart Institute, 5000 Bélanger, Montreal, QC, H1T1C8, Canada. matthieu.pelletier-galarneau@icm-mhi.org.
Abstract
BACKGROUND: We examined the use of [18F]FDG-PET/CT for the diagnosis of native valve endocarditis (NVE). METHODS: PET/CT images in patients with suspected NVE were retrospectively reviewed independently by two experienced physicians blinded to all clinical information. The gold standard consisted of surgical findings, when available, or the modified Duke criteria. RESULTS: Fifty four subjects were included, 31 (57%) with a diagnosis of NVE. [18F]FDG-PET/CT correctly identified 21/31 (67.7%) subjects, yielding a sensitivity and specificity of 68% (95% CI 49-83%) and 100% (95% CI 85-100%), respectively. The sensitivity and specificity of the modified Duke criteria were 48% and 74%, respectively. Positive and negative predictive values of PET were 100% (95% CI 84-100%) and 70% (95% CI 51-84%), respectively. Modifying the Duke criteria to include [18F]FDG-PET positivity as a major criterion increased sensitivity to 77% without affecting specificity and led to the correct reclassification of 8/18 (44.4%) subjects from Possible IE to Definite IE. CONCLUSION: The addition of a positive [18F]FDG-PET/CT as a major criterion in the modified Duke Criteria improved performance of the criteria for the diagnosis of NVE, particularly in those subjects with Possible IE.
BACKGROUND: We examined the use of [18F]FDG-PET/CT for the diagnosis of native valve endocarditis (NVE). METHODS: PET/CT images in patients with suspected NVE were retrospectively reviewed independently by two experienced physicians blinded to all clinical information. The gold standard consisted of surgical findings, when available, or the modified Duke criteria. RESULTS: Fifty four subjects were included, 31 (57%) with a diagnosis of NVE. [18F]FDG-PET/CT correctly identified 21/31 (67.7%) subjects, yielding a sensitivity and specificity of 68% (95% CI 49-83%) and 100% (95% CI 85-100%), respectively. The sensitivity and specificity of the modified Duke criteria were 48% and 74%, respectively. Positive and negative predictive values of PET were 100% (95% CI 84-100%) and 70% (95% CI 51-84%), respectively. Modifying the Duke criteria to include [18F]FDG-PET positivity as a major criterion increased sensitivity to 77% without affecting specificity and led to the correct reclassification of 8/18 (44.4%) subjects from Possible IE to Definite IE. CONCLUSION: The addition of a positive [18F]FDG-PET/CT as a major criterion in the modified Duke Criteria improved performance of the criteria for the diagnosis of NVE, particularly in those subjects with Possible IE.
Authors: D Raoult; J P Casalta; H Richet; M Khan; E Bernit; C Rovery; S Branger; F Gouriet; G Imbert; E Bothello; F Collart; G Habib Journal: J Clin Microbiol Date: 2005-10 Impact factor: 5.948
Authors: Arthur J Morris; Dragana Drinkovic; Sudha Pottumarthy; Marianne G Strickett; Donald MacCulloch; Neil Lambie; Alan R Kerr Journal: Clin Infect Dis Date: 2003-03-04 Impact factor: 9.079
Authors: David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell Journal: Arch Intern Med Date: 2009-03-09
Authors: Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Joop J P Kouijzer; Daniëlle J Noordermeer; Wouter J van Leeuwen; Nelianne J Verkaik; Kirby R Lattwein Journal: Front Cell Dev Biol Date: 2022-10-03
Authors: Sabine Julia Maria Sag; Karin Menhart; Jirka Grosse; Florian Hitzenbichler; Frank Hanses; Arno Mohr; Bernd Salzberger; Matthäus Zerdzitzki; Michael Hilker; Leopold Rupprecht; Dirk Hellwig; Christof Schmid; Lars Siegfried Maier; Can Martin Sag Journal: J Nucl Cardiol Date: 2020-12-22 Impact factor: 3.872
Authors: Christopher P Primus; Thomas A Clay; Maria S McCue; Kit Wong; Rakesh Uppal; Shirish Ambekar; Satya Das; Sanjeev Bhattacharyya; L Ceri Davies; Simon Woldman; Leon J Menezes Journal: J Nucl Cardiol Date: 2021-06-24 Impact factor: 3.872